Business Services
Pharmaceutical Business Services – News, analysis and company profiles
Actimed Therapeutics successfully closes second tranche of £10m seed financing to progress pipeline for treatment of cancer cachexia and other muscle wasting disorders
January 4, 2023 Business Services
London, UK – 4 January 2023. Actimed Therapeutics Ltd, a UK based clinical stage specialty pharmaceutical company focused on bringing …
Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
January 3, 2023 Business Services
Milan, Italy, Jan. 3, 2023, 07:00 am CET – Newron Pharmaceuticals S.p.A.
Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
January 3, 2023 Business Services
BEERSE, BELGIUM, 3 January 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a …
OSE Immunotherapeutics Announces First Patient Dosed with Anti-PD1 Monoclonal Antibody OSE-279 in a Phase 1/2 Clinical Trial in Advanced Solid Tumors or Lymphomas
December 22, 2022 Business Services
Nantes, France – December 22,
Sosei Heptares’ Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity
December 21, 2022 Business Services
Tokyo, Japan and Cambridge, UK, 21 December 2022 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …
Poolbeg identifies new potential drug candidates for Respiratory Syncytial Virus infections as part of Artificial Intelligence Programme
December 21, 2022 Business Services
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical company, announces that it …
NICE EXTENDS USE OF ENHERTU® ▼ (TRASTUZUMAB DERUXTECAN) TO EARLIER IN THE TREATMENT OF HER2 POSITIVE METASTATIC BREAST CANCER
December 20, 2022 Business Services
Uxbridge and London, UK – (20 December 2022) – Daiichi Sankyo UK Limited and AstraZeneca UK Limited today welcome the …
Psoriasis community comes together and calls for collective action to help improve the lives of people with psoriasis
December 19, 2022 Business Services
Slough, UK, 15 December 2022 – UCB, a global biopharmaceutical company, has announced results from the Epicensus programme, published in …
Sosei Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases
December 19, 2022 Business Services
Tokyo, Japan and Cambridge, UK, 16 December 2022 – Sosei Group Corporation (“the Company”; TSE: 4565) announces it has entered …
Alchemab Therapeutics and Medicines Discovery Catapult awarded £1.7 million grant from Innovate UK to accelerate development of disease-modifying therapy for Huntington’s Disease
December 19, 2022 Business Services
Cambridge, UK. December 16 2022 – Alchemab Therapeutics, a biotechnology company unlocking new therapies from within the immune system, today …
FlyPharma Conference Middle East: New location announced
December 14, 2022 Business Services
FlyPharma Conferences are pleased to announce an exciting new addition to its event portfolio: FlyPharma Middle East. Taking place in …
David Brocklehurst
December 14, 2022 Business Services
London, UK, 12 December 2022 – AstraZeneca UK announces the appointment of David Brocklehurst as Head of Oncology in the …
Aptamer Group sign deals to develop Optimer solutions
December 5, 2022 Business Services
Aptamer Group has announced a selection of contracts aimed at exploring Optimer technology, which will offer new strategies for therapeutics …
Peter Williams
November 29, 2022 Business Services
Incyte has announced its appointment of Peter Williams as General Manager for the UK and Ireland division. His new role …
Scott Curley
November 28, 2022 Business Services
Following a positive NICE recommendation for VAZKEPA® (icosapent ethyl), which has allowed Amarin to continue with its commercial expansion, Amarin …
Latest content
Pharma sees climate disruption as growing supply-chain risk
September 11, 2026
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026
